To Grow

Faster and Healthier

 

Toward Sustainable Agricultural Systems in the 21st Century

AFINGEN, Inc. is a molecular biology startup to improve the beneficial traits of commerciality competitive field crops.

Management Team

Carolyn Fritz, M.B.A

Biotech-Business Consultant

Carolyn Fritz, M.B.A. has over twenty years of experience in successfully building industrial biotechnology businesses. From 2004-2014, she built Allylix from a startup, raising $34 million in venture financing, creating a pipeline of products for the flavor & fragrance and insect control markets, establishing key strategic partnerships, and scaling up and commercializing the first two products, to the successful sale of the company to a European biotechnology company, Evolva, in 2014. From 1999 to 2004, at Dow Chemical, she built a renewable chemical business and a biopharmaceutical contract manufacturing business. From 1993 to 1999, at Cargill, she built a plant biotechnology business focused on developing new food ingredients and industrial products from canola oil. As part of the Afingen team, she advises strategy and commercialization plans to penetrate the markets and build the company.

Kenneth Davenport, Ph.D.

Agtech Strategy Consultant

Kenneth Davenport, Ph.D. is an agricultural industry veteran, having served in leadership and executive capacities as Vice President of Strategy & CTO of Chromatin, Inc., Director of New Business Ventures with Bayer CropScience, GmbH, and CEO of ArborGen, LLC. Ken has held numerous leadership and executive roles focused on strategy and its implementation at the leading edge of novel technology and unique commercial opportunities ranging from chemistry and biotechnology to biopharma and agricultural (e.g., cotton, forestry, specialty crops) industries. Prior to entry into the ag-biotech, seed, and related industries, he served as Director of Central Research for Hoechst Celanese. As part of the Afingen team, he places particular emphasis on Afingen’s product development; regulatory, intellectual property and out-licensing strategies; and approaches to third-party leaders in the ag-biotech, planting seed, and related industries.

Ai Oikawa, Ph.D.

CEO/CSO

Ai Oikawa, Ph.D. leads Afingen R&D and business teams since Afingen’s inception in 2014. She earned her Ph.D. in bioprocessing engineering and has more than 15 years of experience in genetics and molecular biology. She is an expert on bioinformatics experiments related to regulatory gene networks, transcription factors, and evolutionarily conserved promoter cis-elements across organisms. Her research has been awarded by Small Business Innovation Research (SBIR) programs from the U.S. Department of Energy (DOE), United States Department of Agriculture (USDA), and The National Aeronautics and Space Administration (NASA), and grant programs from Japanese Society of Plant Physiologists (JSPP), Yamada Science Foundation (YSF), and Life Science Foundation. While being Afingen’s R&D team leader, she has been an affiliate scientist and industry advisory committee member at Lawrence Berkeley National Laboratory’s DOE Joint BioEnergy Institute. Her R&D team is responsible for DNA assembly, molecular biology, phenotype and metabolite analysis to expand the Afingen’s fast-growth technology to commercially competitive crops.

Advisory Board

Bill Shelander, M.B.A.

Bill Shelander, M.B.A. is Co-Director of Cleantech to Market program at the University of California, Berkeley, Haas School of Business, and had been the Business Development expert for Lawrence Berkeley National Laboratory, a position aimed at enhancing the entrepreneurial awareness within the Lab’s research community with an emphasis on helping to create startups. He has over 20 years of experience managing nearly $180 million in venture funds and returned over $600 million. He has invested in and helped to start dozens of high technology companies. He has seen both investment failures and successes with a distinguished track record as an officer or director of companies acquired or listed on NASDAQ. He has a BS in Systems Engineering with a minor in physics, an MS in Chemical Engineering, and an MBA from Stanford.

Prof. Henrik Scheller, Ph.D.

Prof. Henrik Scheller, Ph.D. is Vice President of the Feedstocks Division at the Joint BioEnergy Institute, Senior scientist at Lawrence Berkeley National Laboratory and an adjunct professor at UC Berkeley. He has been leading research groups working on understanding cell wall biosynthesis mechanisms and genetic engineering for the tissue-specific accumulation of targeted cell wall compounds. He has worked in the field of plant cell walls for more than two decades, and his reputation in plant molecular biology and biochemistry is internationally recognized in the field.

Dominique Loque Ph.D.

Dominique Loque Ph.D. is a research group leader of disease control at Bayer Crop Science and former director of Cell wall Engineering group at Joint BioEnergy Institute and Lawrence Berkley National Laboratory. He received his Ph.D. at Hohenheim University, Germany and worked on the physiological and molecular characterization of ammonium transporter in plants. He moved to the Carnegie Institution for Science at Stanford University to work on post-translational regulation of trimeric ammonium transporter complexes and its role in ammonium update. In 2008, he joined the Joint BioEnergy Institute at Lawrence Berkeley National laboratory to establish his research group on plant cell wall engineering and plant synthetic biology. His primary interests are discoveries and innovations.

Contact

Please enter your name.
Please enter a message.